Anti-Saccharomyces cerevisiae antibody is not useful to differentiate between Crohn's disease and intestinal tuberculosis in India

Journal of Postgraduate Medicine

Volumn 53, Issue 3, 2007, Pages 166-170

  Ghoshal, U C ^a   Ghoshal, U ^a   Singh, H ^a   Tiwari, S ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Crohn's disease; Gastrointestinal tuberculosis; Tropical country; Ulcerative colitis

Indexed keywords

AZATHIOPRINE; ETHAMBUTOL; FUNGUS ANTIBODY; IMMUNOGLOBULIN G; INFLIXIMAB; ISONIAZID; MESALAZINE; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; CHI SQUARE TEST; CLINICAL ARTICLE; COLON CARCINOMA; CONTROLLED STUDY; CROHN DISEASE; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INDIA; INTESTINE TUBERCULOSIS; MALE; RANK SUM TEST; SACCHAROMYCES CEREVISIAE; SERODIAGNOSIS; SEROLOGY; STATISTICAL ANALYSIS; YATES CONTINUITY CORRECTION;

EID: 34548011220     PISSN: 00223859     EISSN: None     Source Type: Journal    
DOI: 10.4103/0022-3859.33857     Document Type: Article

References (35)

1. Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002;347:417-29.
2. Keshavarzian A, Gupta S, Saverymuttu SH, Hodgson HJ. Are there ethnic differences in inflammatory bowel disease? Indian J Gastroenterol 1986;5:95-7.
3. Congilosi SM, Rosendale DE, Herman DL. Crohn's disease - a rare disorder in American Indians. West J Med 1992;157:682.
4. Pai CG, Khandige GK. Is Crohn's disease rare in India? Indian J Gastroenterol 2000;19:17-20.
5. Ranjan P, Ghoshal UC, Aggarwal R, Pandey R, Misra A, Naik S, et al. Etiological spectrum of sporadic malabsorption syndrome in northern Indian adults at a tertiary hospital. Indian J Gastroenterol 2004;23:94-8.
6. Ray G, Banerjee PK, Ghoshal UC, Dhar K, Pal BB, Biswas AD, et al. Etiology and management of obscure gastrointestinal bleed - an appraisal from eastern India. Indian J Gastroenterol 2001;20:90-3.
7. Jayanthi V, Robinson RJ, Malathi S, Rani B, Balambal R, Chari S, et al. Does Crohn's disease need differentiation from tuberculosis? J Gastroenterol Hepatol 1996;11:183-6.
8. Zhou ZY, Luo HS. Differential diagnosis between Crohn's disease and intestinal tuberculosis in China. Int J Clin Pract 2006;60:212-4.
9. Pulimood AB, Ramakrishna BS, Kurian G, Peter S, Patra S, Mathan VI, et al. Endoscopic mucosal biopsies are useful in distinguishing granulomatous colitis due to Crohn's disease from tuberculosis. Gut 1999;45:537-41.
10. Pulimood AB, Peter S, Ramakrishna B, Chacko A, Jeyamani R, Jeyaseelan L, et al. Segmental colonoscopic biopsies in the differentiation of ileocolic tuberculosis from Crohn's disease. J Gastroenterol Hepatol 2005;20:688-96.
11. Annese V, Piepoli A, Perri F, Lombardi G, Latiano A, Napolitano G, et al. Anti-Saccharomyces cerevisiae mannan antibodies in inflammatory bowel disease: Comparison of different assays and correlation with clinical features. Aliment Pharmacol Ther 2004;20:1143-52.
12. Bossuyt X. Serologic markers in inflammatory bowel disease. Clin Chem 2006;52:171-81.
13. Buckland MS, Mylonaki M, Rampton D, Longhurst HJ. Serological markers (anti-Saccharomyces cerevisiae mannan antibodies and antineutrophil cytoplasmic antibodies) in inflammatory bowel disease: Diagnostic utility and phenotypic correlation. Clin Diagn Lab Immunol 2005;12:1328-30.
14. Hisabe T, Matsui T, Sakurai T, Murakami Y, Tanabe H, Matake H, et al. Anti-Saccharomyces cerevisiae antibodies in Japanese patients with inflammatory bowel disease: Diagnostic accuracy and clinical value. J Gastroenterol 2003;38:121-6.
15. Dassopoulos T. Diagnostic methodologies: Serology, endoscopy and radiology. Curr Gastroenterol Rep 2001;3:491-9.
16. Kim BG, Kim YS, Kim JS, Jung HC, Song IS. Diagnostic role of anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic antibodies in patients with inflammatory bowel disease. Dis Colon Rectum 2002;45:1062-9.
17. Hyams JS, Mandel F, Ferry GD, Gryboski JD, Kibort PM, Kirschner BS, et al. Relationship of common laboratory parameters to the activity of Crohn's disease in children. J Pediatr Gastroenterol Nutr 1992;14:216-22.
18. Makharia GK, Sachdev V, Gupta R, Lal S, Pandey RM. Anti-Saccharomyces cerevisiae antibody does not differentiate between Crohn's disease and intestinal tuberculosis. Dig Dis Sci 2007;52:33-9.
19. Lunn PG, Northrop-Clewes CA, Downes RM. Intestinal permeability, mucosal injury and growth faltering in Gambian infants. Lancet 1991;338:907-10.
20. Wood GM, Gearty JC, Cooper BT. Small bowel morphology in British Indian and Afro-Caribbean subjects: Evidence of tropical enteropathy. Gut 1991;32:256-9.
21. Baker SJ, Jacob R, Mathan VI. An evaluation of the 5 g D-xylose absorption test, with fractional urine collections, in subjects living in Southern India. Indian J Med Res 1971;59:1869-77.
22. Harrer M, Reinisch W, Dejaco C, Kratzer V, Gmeiner M, Miehsler W, et al. Do high serum levels of anti-Saccharomyces cerevisiae antibodies result from a leakiness of the gut barrier in Crohn's disease? Eur J Gastroenterol Hepatol 2003;15:1281-5.
23. Joossens S, Suenaert P, Noman M, Vermeire S, Rutgeerts P. Saccharomyces boulardii in Crohn's disease: Effect on anti-Saccharomyces cerevisiae antibodies and intestinal permeability. Inflamm Bowel Dis 2005;11:863-4.
24. Barta Z, Csipo I, Szabo GG, Szegedi G. Seroreactivity against Saccharomyces cerevisiae in patients with Crohn's disease and celiac disease. World J Gastroenterol 2003;9:2308-12.
25. Choi CH, Kim TI, Kim BC, Shin SJ, Lee SK, Kim WH, et al. Anti-Saccharomyces cerevisiae antibody in intestinal Behcet's disease patients: relation to clinical course. Dis Colon Rectum 2006;49:1849-59.
26. Condino AA, Hoffenberg EJ, Accurso F, Penvari C, Anthony M, Gralla J, et al. Frequency of ASCA seropositivity in children with cystic fibrosis. J Pediatr Gastroenterol Nutr 2005;41:23-6.
27. Granito A, Zauli D, Muratori P, Muratori L, Grassi A, Bortolotti R, et al. Anti-Saccharomyces cerevisiae and perinuclear anti-neutrophil cytoplasmic antibodies in coeliac disease before and after gluten-free diet. Aliment Pharmacol Ther 2005;21:881-7.
28. Hoffman IE, Demetter P, Peeters M, De Vos M, Mielants H, Veys EM, et al. Anti-Saccharomyces cerevisiae IgA antibodies are raised in ankylosing spondylitis and undifferentiated spondyloarthropathy. Ann Rheum Dis 2003;62:455-9.
29. Bjarnason I, MacPherson A, Hollander D. Intestinal permeability: An overview. Gastroenterology 1995;108:1566-81.
30. Fink MP. Intestinal epithelial hyperpermeability: Update on the pathogenesis of gut mucosal barrier dysfunction in critical illness. Curr Opin Crit Care 2003;9:143-51.
31. Kilic ZM, Tunc B, Ayaz S, Filik L, Aktas S, Parlak E, et al. Antineutrophil cytoplasmic autoantibodies and anti-Saccharomyces cerevisiae antibodies in inflammatory bowel diseases. Turk J Gastroenterol 2004;15:238-42.
32. Peeters M, Joossens S, Vermeire S, Vlietinck R, Bossuyt X, Rutgeerts P. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease. Am J Gastroenterol 2001;96:730-4.
33. Glas J, Torok HP, Vilsmaier F, Herbinger KH, Hoelscher M, Folwaczny C. Anti-saccharomyces cerevisiae antibodies in patients with inflammatory bowel disease and their first-degree relatives: Potential clinical value. Digestion 2002;66:173-7.
34. Ainsworth M, Eriksen J, Rasmussen JW, Schaffalitzky de Muckadell OB. Intestinal permeability of 51Cr-labelled ethylenediaminetetraacetic acid in patients with Crohn's disease and their healthy relatives. Scand J Gastroenterol 1989;24:993-8.
35. Breslin NP, Nash C, Hilsden RJ, Hershfield NB, Price LM, Meddings JB, et al. Intestinal permeability is increased in a proportion of spouses of patients with Crohn's disease. Am J Gastroenterol 2001;96:2934-8.